Vancomycin drug monitoring in infants with CoNS sepsis-target attainment, microbiological response and nephrotoxicity
- 1 October 2019
- journal article
- research article
- Published by Springer Nature in Journal of Perinatology
- Vol. 40 (1) , 97-104
Abstract
Objectives To characterize residual vancomycin concentrations (Cmin) and assess the relationships between Cmin, the risk of nephrotoxicity and persistent CoNS sepsis. Methods In this 5-year retrospective study among infants treated with vancomycin, the primary outcome was the proportion of those with a steady state Cmin between 10 and 20 mg/L. The secondary outcomes were nephrotoxicity and persistent CoNS sepsis. Results Of 120 infants included, the median first steady state Cmin was 12.4 mg/L and 77 (64%) had a Cmin between 10 and 20 mg/L. Six percent developed nephrotoxicity. This risk was not associated with Cmin. Of the 30 infants with CoNS sepsis, 17 (57%) had persistent bacteremia, and this risk did not correlate significantly with Cmin, CoNS minimal inhibitory concentration (MIC) for vancomycin, or Cmin/MIC. Conclusions The majority of infants achieved targeted levels of vancomycin, but persistent bacteremia was common. We did not identify a Cmin threshold associated with nephrotoxicity, nor with microbiological clearance.Keywords
This publication has 26 references indexed in Scilit:
- Association between Vancomycin Trough Concentration and Area under the Concentration-Time Curve in NeonatesAntimicrobial Agents and Chemotherapy, 2014
- Determination of Vancomycin Pharmacokinetics in Neonates To Develop Practical Initial Dosing RecommendationsAntimicrobial Agents and Chemotherapy, 2014
- High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S. aureus bacteraemia patientsInternational Journal of Antimicrobial Agents, 2013
- Improved Vancomycin Dosing in Children Using Area Under the Curve ExposureThe Pediatric Infectious Disease Journal, 2013
- Clinical pharmacokinetics of vancomycin in the neonate: a reviewClinics, 2012
- Evaluation of Vancomycin Dosing Regimens in Preterm and Term Neonates Using Monte Carlo SimulationsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012
- Antibiotic Use in Neonatal Intensive Care Units and Adherence With Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial ResistanceThe Pediatric Infectious Disease Journal, 2009
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsAmerican Journal of Health-System Pharmacy, 2009
- Reported Medication Use in the Neonatal Intensive Care Unit: Data From a Large National Data SetPediatrics, 2006
- VancomycinClinical Pharmacokinetics, 2004